Skip to main content
⌘K
·
Launch Terminal
Launch Terminal
Home
SEC Filings
Home
SEC Filings
Filings
Filing Date
Form Type
Company
Description
AI
Link
Learn
MCP
API
Cookie Preferences
TOVX · Form 8-K · Theriva Biologics, Inc. | Signal8
Material events
Financial results
Capital raises
Insider transactions
Fund filings
Advanced filters
Any time
Sort
Filings
Filing Date
Form Type
Company
Description
AI
Link
Browse AI-analysed SEC filings
Page 1 of 81 · 8,027 total
CSTM: 8-K · earnings release
CSTM · 8-K · 2026-10-28
UBS: 6-K · earnings release
UBS · 6-K · 2026-10-28
AXTI: 8-K · material agreement
AXTI · 8-K · 2026-10-28
XXII: 8-K · material agreement
XXII · 8-K · 2026-10-28
ELPW: 6-K · material agreement
ELPW · 6-K · 2026-10-28
AVTR: 8-K · earnings release
AVTR · 8-K · 2026-10-28
ESLT: 6-K · other
ESLT · 6-K · 2026-10-28
KB: 6-K · leadership change
KB · 6-K · 2026-10-28
BIIB: 8-K · earnings release
BIIB · 8-K · 2026-10-28
KEN: 6-K · debt financing
KEN · 6-K · 2026-10-28
EQNR: 6-K · share repurchase
EQNR · 6-K · 2026-10-28
RDWR: 6-K · earnings release
RDWR · 6-K · 2026-10-28
EQNR: 6-K · dividend
EQNR · 6-K · 2026-10-28
XXII: 424B5 · prospectus supplement
XXII · 424B5 · 2026-10-28
DB: 6-K · earnings release
DB · 6-K · 2026-10-28
ING: 6-K · regulatory action
ING · 6-K · 2026-10-28
FDP: 8-K · earnings release
FDP · 8-K · 2026-10-28
VRT: 8-K · earnings release
VRT · 8-K · 2026-10-28
LUV: 424B5 · debt financing
LUV · 424B5 · 2026-10-28
SITE: 10-Q · periodic report
SITE · 10-Q · 2026-10-28
OTIS: 8-K · earnings release
OTIS · 8-K · 2026-10-28
ENLT: 6-K · proxy statement
ENLT · 6-K · 2026-10-28
MSC: 6-K · earnings release
MSC · 6-K · 2026-10-28
SKM: 6-K · earnings release
SKM · 6-K · 2026-10-28
MLCO: 6-K · foreign private issuer
MLCO · 6-K · 2026-10-28
ANL: 6-K · clinical trial
ANL · 6-K · 2026-10-28
HOOD: 10-Q · periodic report
HOOD · 10-Q · 2026-10-27
HDB: 6-K · leadership change
HDB · 6-K · 2026-10-28
NMR: 6-K · earnings release
NMR · 6-K · 2026-10-28
VFC: 8-K · earnings release
VFC · 8-K · 2026-10-28
SITE: 8-K · earnings release
SITE · 8-K · 2026-10-28
SAN: 6-K · regulatory action
SAN · 6-K · 2026-10-28
FCF: 8-K · earnings release
FCF · 8-K · 2026-10-27
RRGB: 8-K · leadership change
RRGB · 8-K · 2026-10-27
OGE: 10-Q · periodic report
OGE · 10-Q · 2026-10-27
ROG: 10-Q · periodic report
ROG · 10-Q · 2026-10-27
SEVN: 8-K · earnings release
SEVN · 8-K · 2026-10-27
OGE: 8-K · earnings release
OGE · 8-K · 2026-10-27
GNRC: 8-K · earnings release
GNRC · 8-K · 2026-10-28
TER: 8-K · earnings release
TER · 8-K · 2026-10-28
MITI: 8-K · leadership change
MITI · 8-K · 2026-10-28
WRN: 6-K · leadership change
WRN · 6-K · 2026-10-28
CLLS: 6-K · clinical trial
CLLS · 6-K · 2026-10-28
SEVN: 10-Q · periodic report
SEVN · 10-Q · 2026-10-27
PAC: 6-K · dividend
PAC · 6-K · 2026-10-28
AUNA: 6-K · other
AUNA · 6-K · 2026-10-28
MCRI: 8-K · earnings release
MCRI · 8-K · 2026-10-27
BAK: 6-K · bankruptcy
BAK · 6-K · 2026-10-28
SPGI: 10-Q · periodic report
SPGI · 10-Q · 2026-10-27
TXN: 424B5 · debt financing
TXN · 424B5 · 2026-10-28
EPAC: 8-K · material agreement
EPAC · 8-K · 2026-10-28
EC: 6-K · foreign private issuer
EC · 6-K · 2026-10-28
CDNS: 10-Q · periodic report
CDNS · 10-Q · 2026-10-27
VLO: 10-Q · periodic report
VLO · 10-Q · 2026-10-27
PDS: 6-K · earnings release
PDS · 6-K · 2026-10-27
IMNN: S-1/A · offering registration
IMNN · S-1/A · 2026-10-27
OPFI: 8-K · earnings release
OPFI · 8-K · 2026-10-27
UNF: 10-K · periodic report
UNF · 10-K · 2026-10-27
TAC: 6-K · dividend
TAC · 6-K · 2026-10-27
QNRX: S-3 · shelf registration
QNRX · S-3 · 2026-10-28
LU: 6-K · earnings release
LU · 6-K · 2026-10-28
PDS: 6-K · earnings release
PDS · 6-K · 2026-10-28
RUSHA: 8-K · earnings release
RUSHA · 8-K · 2026-10-27
APXC: 6-K · prospectus supplement
APXC · 6-K · 2026-10-27
SBEV: S-1 · offering registration
SBEV · S-1 · 2026-10-27
ACRS: 8-K · material agreement
ACRS · 8-K · 2026-10-27
HYFM: 8-K · debt financing
HYFM · 8-K · 2026-10-27
HBAN: 10-Q · periodic report
HBAN · 10-Q · 2026-10-27
MRLN: 424B3 · prospectus supplement
MRLN · 424B3 · 2026-10-27
MRLN: 424B3 · prospectus supplement
MRLN · 424B3 · 2026-10-27
APXC: 6-K · prospectus supplement
APXC · 6-K · 2026-10-27
RCT: 6-K · debt financing
RCT · 6-K · 2026-10-27
EONR: S-1/A · offering registration
EONR · S-1/A · 2026-10-27
FRFHF: 6-K · other
FRFHF · 6-K · 2026-10-27
SPRO: 8-K · leadership change
SPRO · 8-K · 2026-10-27
ACRS: 424B5 · prospectus supplement
ACRS · 424B5 · 2026-10-27
SFBC: 8-K · earnings release
SFBC · 8-K · 2026-10-27
NOA: 6-K · other
NOA · 6-K · 2026-10-27
EPAC: 8-K · leadership change
EPAC · 8-K · 2026-10-27
RNST: 8-K · acquisition merger
RNST · 8-K · 2026-10-27
ZURA: S-3 · shelf registration
ZURA · S-3 · 2026-10-27
BNGO: S-1 · offering registration
BNGO · S-1 · 2026-10-27
MOD: 8-K · material agreement
MOD · 8-K · 2026-10-27
CABR: S-1 · offering registration
CABR · S-1 · 2026-10-27
IQV: 10-Q · periodic report
IQV · 10-Q · 2026-10-27
WSO: 8-K · debt financing
WSO · 8-K · 2026-10-27
RCL: 10-Q · periodic report
RCL · 10-Q · 2026-10-27
ICLR: 6-K · periodic report
ICLR · 6-K · 2026-10-27
BKR: 8-K · earnings release
BKR · 8-K · 2026-10-27
LOMA: 6-K · debt financing
LOMA · 6-K · 2026-10-27
PYPL: 10-Q · periodic report
PYPL · 10-Q · 2026-10-27
ENS: 8-K · acquisition merger
ENS · 8-K · 2026-10-27
UHS: 8-K · earnings release
UHS · 8-K · 2026-10-27
OCFC: 8-K · earnings release
OCFC · 8-K · 2026-10-27
BUSE: 8-K · earnings release
BUSE · 8-K · 2026-10-27
VNRX: 8-K · debt financing
VNRX · 8-K · 2026-10-27
VTIX: 8-K · earnings release
VTIX · 8-K · 2026-10-27
GOAI: 424B3 · prospectus supplement
GOAI · 424B3 · 2026-10-27
CPOP: 6-K · proxy statement
CPOP · 6-K · 2026-10-27
CHOW: 6-K · offering registration
CHOW · 6-K · 2026-10-27
1
2
3
4
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
81
Next ›
